Guzmán LKN, Camas ALG, Espinel NNN, Ojeda CAA

Language: Spanish
References: 18
Page:
PDF size: 93.36 Kb.

ABSTRACT

Pharmacological treatment of rheumatic diseases has given priority to non-steroidal anti-inflammatory drugs in the last decades.
Objective: to present the main recommendations contained in the scientific literature on the indication of non-steroidal anti-inflammatory drugs. currently used more regularly in clinical rheumatology.
Development: between September and December 2016, in order to access the scientific publications that are currently presented both in the virtual space and in the specialized libraries, a systematic search was made selecting the library of the Central University of Ecuador, Medline, PubMed and Cochrane as primary sources of information containing research work. A search strategy was outlined using the terms "update on the use of non-steroidal anti-inflammatory drugs in rheumatology" and "recommendations on the indication of non-steroidal anti-inflammatory drugs in rheumatology". Other search criteria were current information - pertaining to the last 5 years - and the preferred languages: Spanish and English. Between 10 and 30 documents that could be classified as scientific articles, textbooks and other publications were retrieved.
Conclusions: in summary, literature points at a wide range of possibilities for the use of non-steroidal anti-inflammatory drugs. in the treatment of rheumatic processes, and to the usefulness of recommendations, based on scientific evidence, on the indication of non-steroidal anti-inflammatory drugs. currently and regularly used in rheumatologic clinical practice. These allow a rational use of these drugs and promote the improvement of health care quality. However, non-steroidal anti-inflammatory drugs. prescription will always depend on the clinical situation and the specific patient, as well as the specialist clinical judgment. To enhance the latter, it is essential to know the treatment alternatives that have stood out over the last years, specific to the approach of rheumatologic diseases.

REFERENCES

1. Crofford LJ. Nonsteroidal anti.inflammatory dugs. En: Harris ED, Budd RC, Firestein GS, Genovese MC, Sergent JS, Ruddy S, Sledge CB, eds. Kelley´s Textbook of Rheumatology. 7th edition. Philadelphia: Edt. Elsevier Saunders;2005: pp. 839-58.

2. Lanasa A, Benitob P, Alonsoc J, Hernández Cruz B, Barón Esquiviase G, Perez-Aísaf A, Calvetg X, García-Llorenteh JF, Gobboi M, Gonzalez-Juanateyj JR. Recomendaciones para una prescripción segura de antiinflamatorios no esteroideos: documento de consenso elaborado por expertos nominados por 3 sociedades científicas (SER-SECAEG). Reumatol Clin [Internet].2014 [citado 2 diciembre 2016];10(2):68-84. Disponible en: http://www.reumatologiaclinica.org/es/recomendaciones-unaprescripcion- segura-antiinflamatorios/articulo/S1699258X13002131/

3. Burmester G, Lanas A, Biasucci L, Hermann M, Lohmander S, Olivieri I.The appropriate use of non-steroidal antiinflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis. 2011;70:818–22.

4. Furst DE. Are there differences among nonsteroidal antiinflammatory drugs?. Comparing acetylated salicylates and nonacetylated nonsteroidal antiinflammatory drugs. Arthitis Rheum. 1994;37:1-9.

5. NiresteinGS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS, eds. Kelley’s Textbook of Rheumatology. 8th Edition. Philadelphia: Edt. Elsevier Saunders;2009.

6. Castellanos Gutiérrez M, Solis Cartas U, Faure Bermúdez A, Villaurrutia Velazco Yd, et al. Gastropatía por antinflamatorios no esteroideos en pacientes con enfermedades reumáticas. Revista Cubana de Reumatología [Internet].2014 [citado 2 diciembre 2016];16(3 Suppl. 1). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/375

7. Ramiro S, Radner H, van der Heijde D, van Tubergen A, Buchbinder R, Aletaha D. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev. 2011;10.

8. Santos Ramírez C, Rosas J, Senabre JM, Santos Soler G, Salas E, Barber X, Sánchez Barrioluengo M. Antiinflamatorios no esteroideos (AINE).[Internet].2013 [citado 2 diciembre 2016]. Disponible en: http://www.svreumatologia.com/wpcontent/ uploads/2013/10/Cap-45-Antiinflamatorios-no-esteroideos.pdf

9. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs - differences and similarities. N Eng J Med. 1991 Jun;324(24):1716-25.

10. Kidd Bl. Langford RM. Wodehouse T. Arthritis and pain. Current approaches in the treatment of arthritic pain. Arthritis Research & Therapy [Internet].2007 [citado 2 diciembre 2016];9(3):214. Disponible en: http://arthritisresearch. com/content/9/3/214

11. Bori Segura G, Hernández Cruz B, Gobbo M, Lanas Arbeloa A, Salazar Páramo M, Terán Estrada L, et al. Uso apropiado de los antiinflamatorios no esteroideos en reumatología: documento de consenso de la Sociedad Española de Reumatología y el Colegio Mexicano de Reumatología. Reumatol Clin. 2009;5:3-12.

12. Strand V, Simon LS, Dougados LS, Sands GH, Bhadra P, Breazna A. Treatment of osteoarthritis with continuous versus intermittent celecoxib. J Rheumatol. 2011;38:2625-34.

13. Luyten FP,Geusens P,Malaise M,de Clerck L, Westhovens R, Raeman F. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Ann Rheum Dis. 2007;66:99-106.

14. L. Gossec L, Smolen JS, Gaujoux Viala C, Ash Z, Mar Ortega H, van der Heijde D. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis. 2012;71:4-12

15. Núñez Cuadros E, Téllez Labao C, Galindo Zavala R, Vera Casaño A. Alteraciones cutáneas con significación reumatológica. Protoc diagn ter pediatr. 2014;1:241-61.

16. Wilcox CM, Allison J, Benzuly K, Borum M, Cryer B, Grosser T. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol. 2006;4:1082-9.

17. Rostom A, Goldkind L, Laine L. Nonsteroidal anti-inflammatory drugs and hepatic toxicity: A systematic review of randomized controlled trials in arthritis patients. Clin Gastroenterol Hepatol. 2005;3:489-98.

18. Soni P, Shell B, Cawkwell G, Li C, Ma H. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: Pooled analysis of 41 randomized controlled trials. Curr Med Res Opin. 2009;5:1841-51.